GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+22.65%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$574M
AUM Growth
+$574M
(+42%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
18.58%
Top 10 Holdings %
Top 10 Hldgs %
55.49%
Holding
49
New
14
Increased
10
Reduced
8
Closed
8
Top Buys
Top Sells
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$34.6M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
$15.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
$11.3M |
| 4 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$9.49M |
| 5 |
Cartesian Therapeutics
RNAC
|
$7.1M |
Sector Composition
| 1 | Healthcare | 89.19% |
| 2 | Technology | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
1
DELISTED
Zogenix, Inc.
ZGNX
| $44.9M | 7.66% | 1,121,331 +100,000 | +10% | +$4M |
|
|
ARNA
2
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $40M | 6.82% | 1,177,119 -180,681 | -13% | -$6.14M |
|
3
Kura Oncology
KURA
$686M
| $33.6M | 5.74% | 2,197,283 +446,396 | +25% | +$6.83M |
|
|
SAGE
4
DELISTED
Sage Therapeutics
SAGE
| $32.9M | 5.62% | 200,000 +90,500 | +83% | +$14.9M |
|
|
GBT
5
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $31.6M | 5.39% | 803,205 +242,707 | +43% | +$9.55M |
|
6
Neurocrine Biosciences
NBIX
$13.8B
| $31M | 5.3% | 400,000 -75,000 | -16% | -$5.82M |
|
7
Rigel Pharmaceuticals
RIGL
$697M
| $30.6M | 5.22% | 7,888,581 -1,217,110 | -13% | -$4.72M |
|
|
FOMX
8
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $28.7M | 4.9% | 4,781,708 | – | – |
|
9
BioCryst Pharmaceuticals
BCRX
$1.74B
| $23.3M | 3.98% | 4,751,883 +3,114,551 | +190% | +$15.3M |
|
|
AIMT
10
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $21.7M | 3.7% | 573,550 +73,550 | +15% | +$2.78M |
|
|
ONCE
11
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $21.1M | 3.61% | +410,900 | New | +$21.1M |
|
12
PTC Therapeutics
PTCT
$3.92B
| $18.1M | 3.09% | 1,085,800 -14,200 | -1% | -$237K |
|
13
NovoCure
NVCR
$1.38B
| $17.8M | 3.03% | 879,286 +701,620 | +395% | +$14.2M |
|
|
CNCE
14
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $17.3M | 2.96% | 669,472 -1,336,739 | -67% | -$34.6M |
|
|
LUMO
15
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $16.1M | 2.75% | +1,987,099 | New | +$16.1M |
|
16
Iovance Biotherapeutics
IOVA
$807M
| $16M | 2.73% | 2,000,000 | – | – |
|
|
SIOX
17
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $15M | 2.56% | 2,850,000 +2,840,321 | +29,345% | +$15M |
|
18
Catalyst Pharmaceutical
CPRX
$2.52B
| $14.9M | 2.55% | +3,817,288 | New | +$14.9M |
|
|
BHVN
19
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $13.5M | 2.3% | +500,192 | New | +$13.5M |
|
20
Savara
SVRA
$567M
| $12.9M | 2.2% | +869,500 | New | +$12.9M |
|
21
Vanda Pharmaceuticals
VNDA
$279M
| $12.1M | 2.07% | 797,531 +300,000 | +60% | +$4.56M |
|
22
Wave Life Sciences
WVE
$1.53B
| $11.6M | 1.98% | +331,085 | New | +$11.6M |
|
|
RVNC
23
DELISTED
Revance Therapeutics, Inc.
RVNC
| $10.7M | 1.83% | +300,000 | New | +$10.7M |
|
|
GWPH
24
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $9.9M | 1.69% | +75,000 | New | +$9.9M |
|
|
DBVT
25
DBV Technologies
DBVT
$264M
| $7.7M | 1.31% | 313,140 -137,748 | -31% | -$3.39M |
|